AstraZeneca UK Limited

Royaume‑Uni


 
Quantité totale PI 774
Rang # Quantité totale PI 1 641
Note d'activité PI 3/5.0    167
Rang # Activité PI 4 138
Parent AstraZeneca PLC
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

45 14
22 25
619 14
35
 
Dernier brevet 2024 - Sars-cov-2 antibodies for treatm...
Premier brevet 1983 - Amide derivatives
Dernière marque 2023 - KAVIGALE
Première marque 1964 - INDERAL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical,...
2023 P/S Pharmaceutical preparations and substances
P/S Pharmaceutical preparations and substances.
Invention Methods for lowering blood sugar with a gliflozin sodium-glucose cotransport 2 inhibitor pharmace...
Invention Methods for lowering blood sugar with a metformin pharmaceutical composition. A method is provid...
Invention Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceu...
Invention Sars-cov-2 antibodies for treatment and prevention of covid-19. The present disclosure provides ...
Invention Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical compo...
Invention Combination of antibody-drug conjugate and bispecific checkpoint inhibitor. A pharmaceutical prod...
P/S pharmaceutical preparations and substances, namely antibodies to viruses
Invention Combination of an antibody specific for a tumor antigen and a cd47 inhibitor. The present inventi...
Invention Sars-cov-2 antibodies and methods of using the same. The present disclosure provides antibodies a...
Invention Combination of antibody-drug conjugate with ezh1 and/or ezh2 inhibitor. A pharmaceutical product,...
Invention Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical comp...
Invention A scoring method for an anti-trop2 antibody‑drug conjugate therapy. A method for predicting how a...
2022 Invention Combination of antibody-drug conjugate and rasg12c inhibitor. A pharmaceutical product for admini...
Invention Combination of antibody-drug conjugate and atr inhibitor. A pharmaceutical product for administra...
Invention Egfr-cmet–targeted compounds and uses thereof. Compounds, e.g., radioimmunoconjugates, including ...
Invention Combination of antibody-drug conjugate and parp1 selective inhibitor. A pharmaceutical product fo...
Invention Composition for treatment and prevention of covid-19. The present disclosure provides pharmaceut...
Invention Composition for treatment and prevention of covid-19. The present disclosure provides pharmaceuti...
Invention Methods for lowering blood sugar with a metformin pharmaceutical composition. A method is provide...
Invention Systems and methods for dispensing a statin medication over the counter. A method is provided fo...
Invention Compositions and methods for inducing an immune response. The invention relates to A composition...
Invention Methods for treating erectile dysfunction with a cgmp-specific phosphodiesterase 5 inhibitor phar...
Invention Compositions and methods for inducing an immune response. The invention relates to A composition ...
Invention Systems and methods for managing prediabetes with a gliflozin sodium-glucose cotransport 2 inhibi...
2021 Invention Methods of producing adenovirus. Methods for the production of adenoviruses which are suitable f...
Invention Methods of producing adenovirus. Methods for the production of adenoviruses which are suitable fo...
Invention Methods of purifying adenovirus. Methods of purifying adenovirus that can be performed on a large...
Invention Methods of purifying adenovirus. Methods of purifying adenovirus that can be performed on a larg...
P/S Pharmaceutical preparations and substances, namely pharmaceutical antibodies for use as antiviral...
P/S Pharmaceutical preparations and substances, namely antibodies for use as anti-infectives for huma...
Invention Pharmaceutical formulation. Described herein are stable pharmaceutical formulations for bioactiv...
Invention Pharmaceutical formulation. Described herein are stable pharmaceutical formulations for bioactive...
Invention A scoring method for an anti-her2 antibody-drug conjugate therapy. A method for predicting how a ...
Invention Sars-cov-2 antibodies for treatment and prevention of covid-19. The present disclosure provides a...
Invention Sars-cov-2 proteins, anti-sars-cov-2 antibodies, and methods of using the same. The present disc...
Invention Sars-cov-2 proteins, anti-sars-cov-2 antibodies, and methods of using the same. The present discl...
Invention Combination of antibody-drug conjugate and cdk9 inhibitor. A pharmaceutical product for administ...
Invention Combination of antibody-drug conjugate and atm inhibitor. A pharmaceutical product for administra...
Invention Combination of antibody-drug conjugate and cdk9 inhibitor. A pharmaceutical product for administr...
Invention Combination of antibody-drug conjugate and aurora b inhibitor. A pharmaceutical product for admin...
P/S Pharmaceutical preparations and substances, namely, vaccines
P/S Pharmaceutical preparations and substances, namely, vaccines for viruses for human use
2020 P/S pharmaceutical preparation and substance, namely, antibodies
P/S Pharmaceutical preparations and substances, namely, vaccines for viruses for human use.
P/S Computer software, namely, mobile applications for the collection, exchange and analysis of healt...
P/S Computer software, namely, downloadable mobile applications for the collection, exchange and anal...
P/S Pharmaceutical preparations and substances, namely, vaccines for human use.
2015 P/S Pharmaceutical preparations and substances. Surgical, medical and dental apparatus and instrument...
2009 P/S Pharmaceutical preparation for the treatment of pain and inflammation.
2008 P/S Pharmaceutical preparations and substances for the treatment and prevention of cancer.
P/S Pharmaceutical preparations and substances for use in the treatment and prevention of cancer.
2007 P/S Pharmaceutical preparations and substances for the prevention and/or treatment of psychological a...